Dynavax Technologies
DVAX
$11.99
Share price
1.44%
Change (1 day)
4.44%
Change (1 year)
Categories
Dynavax Technologies (DVAX) - Total assets
Total assets on the balance sheet as of March 2024 : $0.98 B
According to Dynavax Technologies 's latest financial reports the company's total assets are $0.98 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Dynavax Technologies - Total assets on balance sheet (from 2003 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.99 B | 1.14% |
| 2022-12-31 | $0.98 B | -5.14% |
| 2021-12-31 | $1.03 B | 194.18% |
| 2020-12-31 | $0.35 B | 26.59% |
| 2019-12-31 | $0.27 B | 32.33% |
| 2018-12-31 | $0.21 B | -3.61% |
| 2017-12-31 | $0.21 B | 99.48% |
| 2016-12-31 | $0.10 B | -49.37% |
| 2015-12-31 | $0.21 B | 56.65% |
| 2014-12-31 | $0.13 B | -32.42% |
| 2013-12-31 | $0.20 B | 46.42% |
| 2012-12-31 | $0.13 B | 4.21% |
| 2011-12-31 | $0.13 B | 59.17% |
| 2010-12-31 | $84.24 M | 66.93% |
| 2009-12-31 | $50.47 M | -44.31% |
| 2008-12-31 | $90.62 M | -24.76% |
| 2007-12-31 | $0.12 B | 17.07% |
| 2006-12-31 | $0.10 B | 28.46% |
| 2005-12-31 | $80.09 M | 8.75% |
| 2004-12-31 | $73.64 M | 133.17% |
| 2003-12-31 | $31.58 M | 0.34% |
| 2002-12-31 | $31.47 M | 108.23% |
| 2001-12-31 | $15.11 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $221.09 B | 22,310.59% | 🇺🇸 USA |
 Amgen AMGN | $92.98 B | 9,324.62% | 🇺🇸 USA |
 Biogen BIIB | $26.56 B | 2,592.94% | 🇺🇸 USA |
 Gilead Sciences GILD | $56.29 B | 5,605.86% | 🇺🇸 USA |
 Merck MRK | $105.84 B | 10,629.04% | 🇺🇸 USA |
 AstraZeneca AZN | $102.29 B | 10,268.60% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $73.94 B | 7,394.88% | 🇬🇧 UK |
 Agenus
AGEN | $0.25 B | -73.99% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $42.77 B | 4,235.55% | 🇮🇱 Israel |